Cargando…
Liraglutide in the treatment of heart failure: insight from FIGHT and LIVE
There are many glucose-lowering agents used in patients with heart failure, showing mixed results, this study was conducted to determine the effect of liraglutide, a glucagon-like peptide-1 analogue, on the treatment of patients with heart failure. Patients from the FIGHT and LIVE trials were includ...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7339504/ https://www.ncbi.nlm.nih.gov/pubmed/32631360 http://dx.doi.org/10.1186/s12933-020-01088-3 |